These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 34977151)
1. Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer. Deng T; Xiao Y; Dai Y; Xie L; Li X Front Mol Biosci; 2021; 8():743376. PubMed ID: 34977151 [TBL] [Abstract][Full Text] [Related]
3. Androgen Receptor-Related Non-coding RNAs in Prostate Cancer. Yang Y; Liu KY; Liu Q; Cao Q Front Cell Dev Biol; 2021; 9():660853. PubMed ID: 33869227 [TBL] [Abstract][Full Text] [Related]
4. The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells. Palomera-Sanchez Z; Watson GW; Wong CP; Beaver LM; Williams DE; Dashwood RH; Ho E J Nutr Biochem; 2017 Sep; 47():113-119. PubMed ID: 28582660 [TBL] [Abstract][Full Text] [Related]
5. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks. Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251 [TBL] [Abstract][Full Text] [Related]
6. Regulation of protein kinase C-related kinase (PRK) signalling by the TPα and TPβ isoforms of the human thromboxane A O'Sullivan AG; Mulvaney EP; Kinsella BT Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):838-856. PubMed ID: 28108419 [TBL] [Abstract][Full Text] [Related]
7. The epigenetic function of androgen receptor in prostate cancer progression. Sawada T; Kanemoto Y; Kurokawa T; Kato S Front Cell Dev Biol; 2023; 11():1083486. PubMed ID: 37025180 [TBL] [Abstract][Full Text] [Related]
8. Seleno-aspirin compound AS-10 promotes histone acetylation ahead of suppressing androgen receptor transcription, G1 arrest, and apoptosis of prostate cancer cells. Karelia DN; Kim S; Plano D; Sharma AK; Jiang C; Lu J Prostate; 2023 Jan; 83(1):16-29. PubMed ID: 35996318 [TBL] [Abstract][Full Text] [Related]
9. New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer. Godbole AM; Njar VC Prostate Cancer; 2011; 2011():918707. PubMed ID: 22111003 [TBL] [Abstract][Full Text] [Related]
10. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model. Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277 [TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as New Characters in the Plot between Epigenetics and Prostate Cancer. Paone A; Galli R; Fabbri M Front Genet; 2011; 2():62. PubMed ID: 22303357 [TBL] [Abstract][Full Text] [Related]
12. Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Jia L; Shen HC; Wantroba M; Khalid O; Liang G; Wang Q; Gentzschein E; Pinski JK; Stanczyk FZ; Jones PA; Coetzee GA Mol Cell Biol; 2006 Oct; 26(19):7331-41. PubMed ID: 16980632 [TBL] [Abstract][Full Text] [Related]
13. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer. Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811 [TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of AR-mediated transcriptional regulatory network reveals IRF1 as an inhibitor of prostate cancer progression. Cheng Y; Wang D; Jiang J; Huang W; Li D; Luo J; Gu W; Mo W; Wang C; Li Y; Gu S; Xu Y Prostate; 2020 May; 80(8):640-652. PubMed ID: 32282098 [TBL] [Abstract][Full Text] [Related]
15. MLL5, a histone modifying enzyme, regulates androgen receptor activity in prostate cancer cells by recruiting co-regulators, HCF1 and SET1. Lee KH; Kim BC; Jeong CW; Ku JH; Kim HH; Kwak C BMB Rep; 2020 Dec; 53(12):634-639. PubMed ID: 33050986 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic Coregulation of Androgen Receptor Signaling. Fernandes RC; Leach DA; Bevan CL Adv Exp Med Biol; 2022; 1390():277-293. PubMed ID: 36107325 [TBL] [Abstract][Full Text] [Related]
17. Androgen Signaling in Prostate Cancer: When a Friend Turns Foe. Pandey SK; Sabharwal U; Tripathi S; Mishra A; Yadav N; Dwivedi-Agnihotri H Endocr Metab Immune Disord Drug Targets; 2024 May; ():. PubMed ID: 38831575 [TBL] [Abstract][Full Text] [Related]
18. MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer. Wang C; Sun H; Zou R; Zhou T; Wang S; Sun S; Tong C; Luo H; Li Y; Li Z; Wang E; Chen Y; Cao L; Li F; Zhao Y Nucleic Acids Res; 2015 May; 43(10):4893-908. PubMed ID: 25934801 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of androgen receptor gene expression in human prostate cancers. Nakayama T; Watanabe M; Suzuki H; Toyota M; Sekita N; Hirokawa Y; Mizokami A; Ito H; Yatani R; Shiraishi T Lab Invest; 2000 Dec; 80(12):1789-96. PubMed ID: 11140692 [TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo. Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]